Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
Identifieur interne : 001575 ( PubMed/Curation ); précédent : 001574; suivant : 001576Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
Auteurs : Joseph Keating [États-Unis] ; Joshua O. Yukich [États-Unis] ; Sarah Mollenkopf [États-Unis] ; Fabrizio Tediosi [Italie]Source :
- Acta tropica [ 1873-6254 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Filariose lymphatique, Onchocercose.
- économie : Filariose lymphatique, Lutte contre les insectes, Onchocercose.
- Analyse coût-bénéfice, Coûts des soins de santé, Filariose lymphatique, Humains, Onchocercose.
English descriptors
- KwdEn :
- Cost-Benefit Analysis, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (economics), Elephantiasis, Filarial (prevention & control), Health Care Costs, Humans, Insect Control (economics), Onchocerciasis (drug therapy), Onchocerciasis (economics), Onchocerciasis (prevention & control).
- MESH :
- drug therapy : Elephantiasis, Filarial, Onchocerciasis.
- economics : Elephantiasis, Filarial, Insect Control, Onchocerciasis.
- prevention & control : Elephantiasis, Filarial, Onchocerciasis.
- Cost-Benefit Analysis, Health Care Costs, Humans.
Abstract
The control and eventual elimination of neglected tropical disease (NTD) requires the expansion of interventions such as mass drug administration (MDA), vector control, diagnostic testing, and effective treatment. The purpose of this paper is to present the evidence base for decision-makers on the cost and cost-effectiveness of lymphatic filariasis (LF) and onchocerciasis prevention, treatment, and control. A systematic review of the published literature was conducted. All studies that contained primary or secondary data on costs or cost-effectiveness of prevention and control were considered. A total of 52 papers were included for LF and 24 papers were included for onchocerciasis. Large research gaps exist on the synergies and cost of integrating NTD prevention and control programs, as well as research on the role of health information systems, human resource systems, service delivery, and essential medicines and technology for elimination. The literature available on costs and cost-effectiveness of interventions is also generally older, extremely focal geographically and of limited usefulness for developing estimates of the global economic burden of these diseases and prioritizing among various intervention options. Up to date information on the costs and cost-effectiveness of interventions for LF and onchocerciasis prevention are needed given the vastly expanded funding base for the control and elimination of these diseases.
DOI: 10.1016/j.actatropica.2014.03.017
PubMed: 24699086
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001575
Links to Exploration step
pubmed:24699086Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.</title><author><name sortKey="Keating, Joseph" sort="Keating, Joseph" uniqKey="Keating J" first="Joseph" last="Keating">Joseph Keating</name><affiliation wicri:level="1"><nlm:affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jkeating@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Yukich, Joshua O" sort="Yukich, Joshua O" uniqKey="Yukich J" first="Joshua O" last="Yukich">Joshua O. Yukich</name><affiliation wicri:level="1"><nlm:affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jyukich@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Mollenkopf, Sarah" sort="Mollenkopf, Sarah" uniqKey="Mollenkopf S" first="Sarah" last="Mollenkopf">Sarah Mollenkopf</name><affiliation wicri:level="1"><nlm:affiliation>Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: smollenk@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Tediosi, Fabrizio" sort="Tediosi, Fabrizio" uniqKey="Tediosi F" first="Fabrizio" last="Tediosi">Fabrizio Tediosi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4001 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), Università Bocconi, Milan, Italy. Electronic address: fabrizio.tediosi@unibas.ch.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4001 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), Università Bocconi, Milan</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24699086</idno><idno type="pmid">24699086</idno><idno type="doi">10.1016/j.actatropica.2014.03.017</idno><idno type="wicri:Area/PubMed/Corpus">001575</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001575</idno><idno type="wicri:Area/PubMed/Curation">001575</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001575</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.</title><author><name sortKey="Keating, Joseph" sort="Keating, Joseph" uniqKey="Keating J" first="Joseph" last="Keating">Joseph Keating</name><affiliation wicri:level="1"><nlm:affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jkeating@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Yukich, Joshua O" sort="Yukich, Joshua O" uniqKey="Yukich J" first="Joshua O" last="Yukich">Joshua O. Yukich</name><affiliation wicri:level="1"><nlm:affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jyukich@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Mollenkopf, Sarah" sort="Mollenkopf, Sarah" uniqKey="Mollenkopf S" first="Sarah" last="Mollenkopf">Sarah Mollenkopf</name><affiliation wicri:level="1"><nlm:affiliation>Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: smollenk@tulane.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112</wicri:regionArea></affiliation></author><author><name sortKey="Tediosi, Fabrizio" sort="Tediosi, Fabrizio" uniqKey="Tediosi F" first="Fabrizio" last="Tediosi">Fabrizio Tediosi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4001 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), Università Bocconi, Milan, Italy. Electronic address: fabrizio.tediosi@unibas.ch.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4001 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), Università Bocconi, Milan</wicri:regionArea></affiliation></author></analytic><series><title level="j">Acta tropica</title><idno type="eISSN">1873-6254</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cost-Benefit Analysis</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (economics)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Health Care Costs</term><term>Humans</term><term>Insect Control (economics)</term><term>Onchocerciasis (drug therapy)</term><term>Onchocerciasis (economics)</term><term>Onchocerciasis (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Coûts des soins de santé</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (économie)</term><term>Humains</term><term>Lutte contre les insectes (économie)</term><term>Onchocercose ()</term><term>Onchocercose (traitement médicamenteux)</term><term>Onchocercose (économie)</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Onchocerciasis</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Insect Control</term><term>Onchocerciasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Onchocerciasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Onchocercose</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Filariose lymphatique</term><term>Lutte contre les insectes</term><term>Onchocercose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term><term>Health Care Costs</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse coût-bénéfice</term><term>Coûts des soins de santé</term><term>Filariose lymphatique</term><term>Humains</term><term>Onchocercose</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The control and eventual elimination of neglected tropical disease (NTD) requires the expansion of interventions such as mass drug administration (MDA), vector control, diagnostic testing, and effective treatment. The purpose of this paper is to present the evidence base for decision-makers on the cost and cost-effectiveness of lymphatic filariasis (LF) and onchocerciasis prevention, treatment, and control. A systematic review of the published literature was conducted. All studies that contained primary or secondary data on costs or cost-effectiveness of prevention and control were considered. A total of 52 papers were included for LF and 24 papers were included for onchocerciasis. Large research gaps exist on the synergies and cost of integrating NTD prevention and control programs, as well as research on the role of health information systems, human resource systems, service delivery, and essential medicines and technology for elimination. The literature available on costs and cost-effectiveness of interventions is also generally older, extremely focal geographically and of limited usefulness for developing estimates of the global economic burden of these diseases and prioritizing among various intervention options. Up to date information on the costs and cost-effectiveness of interventions for LF and onchocerciasis prevention are needed given the vastly expanded funding base for the control and elimination of these diseases.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24699086</PMID><DateCreated><Year>2014</Year><Month>05</Month><Day>12</Day></DateCreated><DateCompleted><Year>2014</Year><Month>12</Month><Day>18</Day></DateCompleted><DateRevised><Year>2014</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6254</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Acta tropica</Title><ISOAbbreviation>Acta Trop.</ISOAbbreviation></Journal><ArticleTitle>Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.</ArticleTitle><Pagination><MedlinePgn>86-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2014.03.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0001-706X(14)00100-4</ELocationID><Abstract><AbstractText>The control and eventual elimination of neglected tropical disease (NTD) requires the expansion of interventions such as mass drug administration (MDA), vector control, diagnostic testing, and effective treatment. The purpose of this paper is to present the evidence base for decision-makers on the cost and cost-effectiveness of lymphatic filariasis (LF) and onchocerciasis prevention, treatment, and control. A systematic review of the published literature was conducted. All studies that contained primary or secondary data on costs or cost-effectiveness of prevention and control were considered. A total of 52 papers were included for LF and 24 papers were included for onchocerciasis. Large research gaps exist on the synergies and cost of integrating NTD prevention and control programs, as well as research on the role of health information systems, human resource systems, service delivery, and essential medicines and technology for elimination. The literature available on costs and cost-effectiveness of interventions is also generally older, extremely focal geographically and of limited usefulness for developing estimates of the global economic burden of these diseases and prioritizing among various intervention options. Up to date information on the costs and cost-effectiveness of interventions for LF and onchocerciasis prevention are needed given the vastly expanded funding base for the control and elimination of these diseases.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keating</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jkeating@tulane.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yukich</LastName><ForeName>Joshua O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Center for Applied Malaria Research and Evaluation, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States; Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: jyukich@tulane.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollenkopf</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2200, New Orleans, LA 70112, United States. Electronic address: smollenk@tulane.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tediosi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4001 Basel, Switzerland; University of Basel, Switzerland; Centre for Research on Health and Social Care Management (CERGAS), Università Bocconi, Milan, Italy. Electronic address: fabrizio.tediosi@unibas.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Acta Trop</MedlineTA><NlmUniqueID>0370374</NlmUniqueID><ISSNLinking>0001-706X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007300" MajorTopicYN="N">Insect Control</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Control</Keyword><Keyword MajorTopicYN="N">Cost</Keyword><Keyword MajorTopicYN="N">Lymphatic filariasis</Keyword><Keyword MajorTopicYN="N">Onchocerciasis</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24699086</ArticleId><ArticleId IdType="pii">S0001-706X(14)00100-4</ArticleId><ArticleId IdType="doi">10.1016/j.actatropica.2014.03.017</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001575 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001575 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24699086
|texte= Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24699086" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |